Kymera Therapeutics Inc - Wutah bathi EPS kuartalan KYMR

Logo korporat perusahaan Kymera (KYMR)

The foundation of Kymera Therapeutics (KYMR) growth is its authority in developing protein degradation systems to combat cancer. The quarterly EPS growth rate confirms this status, with the parameter value reaching -39.40. Efficiency is supported by the implementation of sustainable laboratory standards and operations within a closed biotech ecosystem, whose success in oncology depends on FDA approval and advances from major pharma partners.

Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan kymeratx.com (KYMR): kanggo periode 04.07.2022 - 18.11.2026

Rincian analitis perusahaan Kymera Therapeutics

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:kymeratx.com - KYMR
Barang unggulan kymeratx.com

Quarterly EPS growth measures the percentage change in net income per share over a rolling period. Professionals utilize this rate to assess business scaling efficiency and cost management. By analyzing the intensity of quarterly EPS growth, an investor determines the sustainability of the financial result. For Kymera Therapeutics (KYMR), this trend is critical due to clinical trial expenses. The risks of therapy development failures could instantaneously wipe out the positive momentum of this metric.

Analisis perusahaan pesaing

GMAB (Genmab) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|EXEL: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NUVL (Nuvalent Therapeutics) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan ideayabio.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Enliven Therapeutics, Inc. (ELVN)|ORIC (ORIC Pharmaceuticals, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan RLAY (Relay Therapeutics Inc)|Wutah bathi resik saben saham sajroning taun lumaku Nurix Pharma|Tyra Biosciences Inc - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Verastem|GLUE (Monte Rosa Therapeutics) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|CGEM: Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|IMRX (immuneering.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan C4 Tx CCCC|Wutah bathi EPS kuartalan BDTX|Repare Therapeutics Inc. - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|PMV Pharmaceuticals, Inc. - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan KPTI|PPCB: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Cyclacel Pharmaceuticals - Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|AADI: Wutah bathi EPS kuartalan|Aileron Therapeutics Inc - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|BPMC (Blueprint Medicines Corp.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan glycomimetics.com GLYC|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan SpringWorks (SWTX)